This inventor holds 3 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignees: Vanderbilt University, Zafgen, Inc.. Active years: 2017-2022.
Company Filing History:
3 out of 1,218 
2 out of 48 
Years Active: 2017-2022
Title: Alan Cherrington: Innovator in Diabetes Treatment
Introduction
Alan Cherrington is a prominent inventor based in Nashville, TN (US). He has made significant contributions to the field of diabetes treatment through his innovative approaches and research. With a total of 3 patents, Cherrington has focused on developing methods that improve the management of diabetes and related health issues.
Latest Patents
Cherrington's latest patents include groundbreaking work on systems, compositions, and methods for treating diabetes. One of his notable disclosures provides methods for treatment that involve co-administering insulin and glucagon to a subject, along with co-formulations comprising both insulin and glucagon. Additionally, he has developed methods for treating overweight subjects, which relate to improving glucose tolerance in patients by administering a MetAP2 inhibitor.
Career Highlights
Throughout his career, Alan Cherrington has worked with esteemed institutions such as Vanderbilt University and Zafgen, Inc. His research has been pivotal in advancing the understanding and treatment of diabetes, showcasing his commitment to improving patient outcomes.
Collaborations
Cherrington has collaborated with notable colleagues, including James E. Vath and Thomas Edward Hughes. These partnerships have further enriched his research and innovation efforts in the field of diabetes treatment.
Conclusion
Alan Cherrington's contributions to diabetes treatment through his patents and collaborations highlight his role as a key innovator in the medical field. His work continues to influence the development of effective therapies for managing diabetes and improving the quality of life for patients.